LUCD

Lucid Diagnostics Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.42

Price (1 Year)

$1.44 $0.4

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %24.4 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %5.1 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma.

Website

Analysis (Turkish): LUCD Hissesi Caiz mi, Helal mi? Lucid Diagnostics Inc. Katılım Analizi